LEADER 01761nam  2200541Ia 450 
001 9910452755903321
005 20200520144314.0
010   $a1-61122-715-1
035   $a(CKB)2550000001041634
035   $a(EBL)3018758
035   $a(SSID)ssj0000854077
035   $a(PQKBManifestationID)12326534
035   $a(PQKBTitleCode)TC0000854077
035   $a(PQKBWorkID)10866971
035   $a(PQKB)11320841
035   $a(MiAaPQ)EBC3018758
035   $a(Au-PeEL)EBL3018758
035   $a(CaPaEBR)ebr10661696
035   $a(OCoLC)836864168
035   $a(EXLCZ)992550000001041634
100   $a20100830d2011      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aClinical aspects of psychopharmacology in childhood and adolescence$b[electronic resource] /$fDonald E. Greydanus ... [et al.], editors
210   $aHauppauge, NY $cNova Science$dc2011
215   $a1 online resource (280 p.)
225 1 $aHealth and human development book series
300   $aDescription based upon print version of record.
311   $a1-61122-135-8 
320   $aIncludes bibliographical references and index.
410  0$aHealth and human development series.
606   $aPediatric psychopharmacology
606   $aAdolescent psychopharmacology
608   $aElectronic books.
615  0$aPediatric psychopharmacology.
615  0$aAdolescent psychopharmacology.
676   $a615/.780835
701   $aGreydanus$b Donald E$0875785
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910452755903321
996   $aClinical aspects of psychopharmacology in childhood and adolescence$91987186
997   $aUNINA